IPO Report: 23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC
DNA, Genomics Company 23andMe Gets SPAC Deal: What Investors Should Know
23andMe is going public via a merger with Richard Branson's blank-check company
VGAC Stock Price Increases Over 10% Pre-Market: Why It Happened